Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M899Revenue (TTM) $M312Net Margin (%)-8.7Altman Z-Score12.9
Enterprise Value $M805EPS (TTM) $-0.8Operating Margin %-7.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-6.6Higher ROA y-yY
Price/Book6.410-y EBITDA Growth Rate %--Quick Ratio3.5Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %--Current Ratio3.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-14.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-19.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M33.4ROIC % (ttm)-69.8Gross Margin Increase y-yN

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXDavid Swensen 2013-03-31 Sold Out -2.8%$26.72 - $29.65
($28.5)
$ 26.95-5%Sold Out0
GHDXDavid Swensen 2012-12-31 Buy 2.8%$26.42 - $36.8
($30.13)
$ 26.95-11%New holding37,861
GHDXDavid Swensen 2011-03-31 Sold Out -0.93%$21.08 - $26.18
($23.29)
$ 26.9516%Sold Out0
GHDXDavid Swensen 2010-12-31 Buy 0.93%$13.18 - $23.52
($17.74)
$ 26.9552%New holding38,243
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BAKER FELIXDirector, 10% Owner 2016-08-15Buy100,000$27.02-0.26view
Cole G BradleyCOO 2016-08-11Sell5,000$28.87-6.65view
Vaughn James JChief Commercial Officer 2016-08-08Sell3,000$28.74-6.23view
Shak StevenChief Scientific Officer 2016-07-19Sell5,000$27.42-1.71view
Cole G BradleyCOO 2016-07-06Sell5,000$26.641.16view
Shak StevenChief Scientific Officer 2016-06-21Sell5,000$25.774.58view
Cole G BradleyCOO 2016-06-09Sell5,000$26.621.24view
Vaughn James JChief Commercial Officer 2016-06-06Sell1,997$28-3.75view
Cole G BradleyCOO 2016-05-16Sell5,000$27.6-2.36view
Febbo Phillip G.Chief Medical Officer 2016-05-10Sell6,324$27.2-0.92view

Quarterly/Annual Reports about GHDX:

News about GHDX:

Articles On GuruFocus.com
Insiders Sell Alphabet, Facebook Aug 19 2016 
CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 

More From Other Websites
Huge 21st Century Fox Buy Highlights Insider Buying: Cavium, Akamai Technologies, Activision... Aug 21 2016
GENOMIC HEALTH INC Financials Aug 18 2016
ETF’s with exposure to Genomic Health, Inc. : August 16, 2016 Aug 16 2016
Genomic Health, Inc. breached its 50 day moving average in a Bearish Manner : GHDX-US : August 15,... Aug 15 2016
Genomic Health, Inc. :GHDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
GENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report Aug 09 2016
Genomic Health (GHDX) Q2 Loss Narrows Y/Y, Sales Beat Aug 03 2016
Edited Transcript of GHDX earnings conference call or presentation 2-Aug-16 8:30pm GMT Aug 02 2016
Genomic Health reports 2Q loss Aug 02 2016
Genomic Health reports 2Q loss Aug 02 2016
GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 02 2016
Genomic Health to Announce Second Quarter 2016 Financial Results and Host Conference Call on... Aug 02 2016
Genomic Health Reports Continued Double-Digit Growth in Announcement of Second Quarter 2016... Aug 02 2016
Q2 2016 Genomic Health Inc Earnings Release - After Market Close Aug 02 2016
Genomic Health to Announce Second Quarter 2016 Financial Results and Host Conference Call on... Jul 26 2016
Genomic Health to Offer Epic Science's AR-V7 test, Shares Up Jul 11 2016
[$$] Test Aids Prostate Cancer Treatment Jul 08 2016
[$$] Test Aids Prostate Cancer Treatment Jul 06 2016
Genomic Health and Epic Sciences Announce Strategic Collaboration to Deliver Novel AR-V7 Liquid... Jul 06 2016
Genomic Health, Inc. – Value Analysis (NASDAQ:GHDX) : July 5, 2016 Jul 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)